Rockefeller Capital Management
BIO icon

Rockefeller Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Rockefeller Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$493K Buy
1,768
+721
+69% +$208K ﹤0.01% 1984
2025
Q4 		$317K Sell
1,047
-501
-32% -$156K ﹤0.01% 2127
2025
Q3 		$434K Buy
+1,548
New +$421K ﹤0.01% 1835
2023
Q2 		– Sell
-534
Closed -$254K – 1829
2023
Q1 		$254K Sell
534
-125
-19% -$58.5K ﹤0.01% 1677
2022
Q4 		$276K Sell
659
-60
-8% -$24.2K ﹤0.01% 1513
2022
Q3 		$299K Buy
719
+124
+21% +$61.8K ﹤0.01% 1470
2022
Q2 		$294K Buy
595
+107
+22% +$55.7K ﹤0.01% 1475
2022
Q1 		$274K Sell
488
-1,119
-70% -$675K ﹤0.01% 1560
2021
Q4 		$1.21M Sell
1,607
-17
-1% -$12.7K 0.01% 983
2021
Q3 		$1.21M Sell
1,624
-106
-6% -$79.4K 0.01% 928
2021
Q2 		$1.11M Sell
1,730
-374
-18% -$228K 0.01% 889
2021
Q1 		$1.2M Buy
2,104
+16
+0.8% +$9.47K 0.01% 728
2020
Q4 		$1.22M Buy
2,088
+140
+7% +$79.7K 0.01% 641
2020
Q3 		$1M Buy
1,948
+285
+17% +$144K 0.01% 596
2020
Q2 		$751K Buy
1,663
+1,361
+451% +$601K 0.01% 600
2020
Q1 		$106K Buy
302
+91
+43% +$33.5K ﹤0.01% 998
2019
Q4 		$78K Buy
211
+5
+2% +$1.76K ﹤0.01% 1027
2019
Q3 		$69K Buy
206
+190
+1,188% +$62K ﹤0.01% 887
2019
Q2 		$5K Sell
16
-248
-94% -$74.3K ﹤0.01% 1416
2019
Q1 		$81K Buy
+264
New +$71.2K ﹤0.01% 804

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rockefeller Capital Management's BIO Position: Q1 2026 in Review

Rockefeller Capital Management increased its Bio-Rad Laboratories Class A (BIO) stake by 69% in Q1 2026, buying an estimated $208K and bringing the position to 1,768 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

Rockefeller Capital Management first reported a position in BIO in Q1 2019 and has held it in 20 quarters since. The position peaked at $1.22M in Q4 2020. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Rockefeller Capital Management held 1,768 shares of Bio-Rad Laboratories Class A worth $493K as of Q1 2026.
  • Rockefeller Capital Management bought 721 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $208K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1984 holding.
  • Rockefeller Capital Management first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and has held it in 20 quarters since.
  • Rockefeller Capital Management's Bio-Rad Laboratories Class A position peaked at $1.22M in Q4 2020.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.